Outcomes for Patients with Metastatic Renal Cell Carcinoma Achieving a Complete Response on Targeted Therapy: A Registry-based Analysis

References

Page 1

	Year	Citations
Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma Robert J. Motzer, Thomas E. Hutson, Piotr Tomczak, New England Journal of Medicine	2007	5.7K
Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial Robert J. Motzer, Bernard Escudier, Stéphane Oudard, The Lancet UrologySurgical OncologyGenitourinary CancerMedicineCancer Treatment	2008	3K
Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III Trial Cora N. Sternberg, Ian D. Davis, Jozef Mardiak, Journal of Clinical Oncology UrologyGenitourinary CancerKidney ResearchMedicineLocally Advanced	2010	2.5K
Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial Bernard Escudier, P. Koralewski, Alain Ravaud, The Lancet UrologySurgical OncologyOncologyGenitourinary CancerInterferon Alfa-2a	2007	2.2K
Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial Brian I. Rini, Bernard Escudier, Piotr Tomczak, The Lancet Comparative EffectivenessUrologyOncologyAxitinib Versus SorafenibGenitourinary Cancer	2011	1.8K
Interferon-Alfa as a Comparative Treatment for Clinical Trials of New Therapies Against Advanced Renal Cell Carcinoma Robert J. Motzer, Jennifer Bacik, Barbara A. Murphy, Journal of Clinical Oncology	2002	1.5K
External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study Daniel Y.C. Heng, Wanling Xie, Meredith M. Regan, The Lancet Oncology External ValidationUrologyPopulation-based StudyGenitourinary CancerMedicine	2013	1K
Bevacizumab Plus Interferon Alfa Compared With Interferon Alfa Monotherapy in Patients With Metastatic Renal Cell Carcinoma: CALGB 90206 Brian I. Rini, Susan Halabi, Jonathan E. Rosenberg, Journal of Clinical Oncology	2008	906
Interferon-Alfa as a Comparative Treatment for Clinical Trials of New Therapies Against Advanced Renal Cell Carcinoma Robert J. Motzer Journal of Clinical Oncology Renal PathologyImmunologyRenal InflammationOncologyGenitourinary Cancer	2002	606
Randomized Phase II Trial of First-Line Treatment With Sorafenib Versus Interferon Alfa-2a in Patients With Metastatic Renal Cell Carcinoma Bernard Escudier, Cezary Szczylik, Thomas E. Hutson, Journal of Clinical Oncology	2009	489

Page 1